Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology

Owing to the introduction of next-generation sequencing (NGS) new challenges for diagnostic algorithms and the interpretation of the results for therapeutic decision making in hemato-oncology have arisen. Recurrent somatic mutations crossing the borders between different hematological entities and s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shumilov, Evgenii (VerfasserIn) , Flach, Johanna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Critical reviews in oncology, hematology
Year: 2018, Jahrgang: 126, Pages: 64-79
ISSN:1879-0461
DOI:10.1016/j.critrevonc.2018.03.020
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.critrevonc.2018.03.020
Volltext
Verfasserangaben:Evgenii Shumilov, Johanna Flach, Thomas Pabst, Martin Fiedler, Anne Angelillo-Scherrer, Lorenz Trümper, Raphael Joncourt, Alexander Kohlmann, Ulrike Bacher

MARC

LEADER 00000caa a2200000 c 4500
001 1677358017
003 DE-627
005 20230427002214.0
007 cr uuu---uuuuu
008 190919s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.critrevonc.2018.03.020  |2 doi 
035 |a (DE-627)1677358017 
035 |a (DE-599)KXP1677358017 
035 |a (OCoLC)1341244316 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Shumilov, Evgenii  |e VerfasserIn  |0 (DE-588)1195187599  |0 (DE-627)1677355387  |4 aut 
245 1 0 |a Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors  |b Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology  |c Evgenii Shumilov, Johanna Flach, Thomas Pabst, Martin Fiedler, Anne Angelillo-Scherrer, Lorenz Trümper, Raphael Joncourt, Alexander Kohlmann, Ulrike Bacher 
264 1 |c 2018 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.09.2019 
520 |a Owing to the introduction of next-generation sequencing (NGS) new challenges for diagnostic algorithms and the interpretation of the results for therapeutic decision making in hemato-oncology have arisen. Recurrent somatic mutations crossing the borders between different hematological entities and solid neoplasms have been detected. In analogy to mutant TP53, the same mutation type may occur in myeloid, B- or T-lymphatic malignancies or solid neoplasms. At the same time, a certain mutation can show different prognostic outcomes in different entities and co-existence of certain mutations may change the prognostic relevance. These insights may spark the investigation of targeted therapies with the same substances across different disease entities. This review article summarizes mutations that can emerge in different hematologic and solid malignancies and summarizes other obstacles in the era of modern molecular diagnostics, such as the phenomenon of "clonal hematopoiesis of indeterminate potential" being difficult to interpret in the individual patient. 
650 4 |a Biomarkers, Tumor 
650 4 |a Cell Lineage 
650 4 |a Clonal hematopoiesis of indeterminate potential (CHIP) 
650 4 |a DNA Mutational Analysis 
650 4 |a Hematologic Neoplasms 
650 4 |a Hematopoiesis 
650 4 |a High-Throughput Nucleotide Sequencing 
650 4 |a Humans 
650 4 |a Lineage crossover 
650 4 |a Modern molecular genetic era 
650 4 |a Mutation 
650 4 |a Neoplasms 
650 4 |a Next-generation sequencing (NGS) 
650 4 |a Prognosis 
650 4 |a Recurrent somatic mutations 
700 1 |a Flach, Johanna  |d 1981-  |e VerfasserIn  |0 (DE-588)1079534865  |0 (DE-627)841212139  |0 (DE-576)451495330  |4 aut 
773 0 8 |i Enthalten in  |t Critical reviews in oncology, hematology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 126(2018), Seite 64-79  |h Online-Ressource  |w (DE-627)320649024  |w (DE-600)2025731-4  |w (DE-576)094108137  |x 1879-0461  |7 nnas  |a Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology 
773 1 8 |g volume:126  |g year:2018  |g pages:64-79  |g extent:16  |a Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology 
856 4 0 |u http://dx.doi.org/10.1016/j.critrevonc.2018.03.020  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190919 
993 |a Article 
994 |a 2018 
998 |g 1079534865  |a Flach, Johanna  |m 1079534865:Flach, Johanna  |d 60000  |d 61200  |e 60000PF1079534865  |e 61200PF1079534865  |k 0/60000/  |k 1/60000/61200/  |p 2 
999 |a KXP-PPN1677358017  |e 3516674962 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Evgenii Shumilov, Johanna Flach, Thomas Pabst, Martin Fiedler, Anne Angelillo-Scherrer, Lorenz Trümper, Raphael Joncourt, Alexander Kohlmann, Ulrike Bacher"]},"id":{"doi":["10.1016/j.critrevonc.2018.03.020"],"eki":["1677358017"]},"recId":"1677358017","title":[{"subtitle":"Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology","title":"Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors","title_sort":"Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Shumilov","given":"Evgenii","roleDisplay":"VerfasserIn","display":"Shumilov, Evgenii","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Flach, Johanna","given":"Johanna","family":"Flach"}],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"language":["eng"],"note":["Gesehen am 19.09.2019"],"physDesc":[{"extent":"16 S."}],"relHost":[{"title":[{"title_sort":"Critical reviews in oncology, hematology","title":"Critical reviews in oncology, hematology"}],"disp":"Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors Diagnostic challenges in the era of high-throughput sequencing in hemato-oncologyCritical reviews in oncology, hematology","language":["eng"],"note":["Gesehen am 04.02.20"],"part":{"text":"126(2018), Seite 64-79","extent":"16","volume":"126","pages":"64-79","year":"2018"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1983/84 -"],"origin":[{"dateIssuedKey":"1983","dateIssuedDisp":"1983-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"recId":"320649024","id":{"eki":["320649024"],"zdb":["2025731-4"],"issn":["1879-0461"]}}]} 
SRT |a SHUMILOVEVGENETICALT2018